Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Otoferlin is a large (~1,997 amino acids) single-pass transmembrane protein of the ferlin family that contains multiple Ca2+-binding C2 domains and a C-terminal membrane anchor; it functions as a key Ca2+ sensor for synaptic vesicle exocytosis at inner hair cell ribbon synapses, where several C2 domains (except C2A) bind Ca2+ and phospholipids to promote and regulate SNARE-mediated membrane fusion and vesicle replenishment; loss-of-function mutations in the OTOF gene cause DFNB9 auditory synaptopathy with severe-to-profound sensorineural deafness, making OTOF a validated therapeutic target for gene replacement approaches in the inner ear
For otoferlin itself: acts as a Ca2+ sensor through several C2 domains to regulate and stimulate SNARE-dependent membrane fusion/exocytosis in hair cells. For investigational gene therapies: gene replacement delivering functional OTOF to restore hair cell synaptic transmission.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Otoferlin (OTOF).